162 related articles for article (PubMed ID: 9414177)
1. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.
Zahnow CA; Younes P; Laucirica R; Rosen JM
J Natl Cancer Inst; 1997 Dec; 89(24):1887-91. PubMed ID: 9414177
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer.
Rask K; Thörn M; Pontén F; Kraaz W; Sundfeldt K; Hedin L; Enerbäck S
Int J Cancer; 2000 May; 86(3):337-43. PubMed ID: 10760820
[TBL] [Abstract][Full Text] [Related]
5. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
6. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
[TBL] [Abstract][Full Text] [Related]
7. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
8. P53 regulates CCAAT/Enhancer binding protein β gene expression.
Hu B; Liu T; Wu Z; Phan SH
Gene; 2023 Oct; 884():147675. PubMed ID: 37541559
[TBL] [Abstract][Full Text] [Related]
9. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
[TBL] [Abstract][Full Text] [Related]
11. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
12. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.
Li Y; Bevilacqua E; Chiribau CB; Majumder M; Wang C; Croniger CM; Snider MD; Johnson PF; Hatzoglou M
J Biol Chem; 2008 Aug; 283(33):22443-56. PubMed ID: 18550528
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functions.
Saint-Auret G; Danan JL; Hiron M; Blache C; Sulpice E; Tendil S; Daveau M; Gidrol X; Salier JP
J Hepatol; 2011 Jun; 54(6):1185-94. PubMed ID: 21145827
[TBL] [Abstract][Full Text] [Related]
14. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression.
Raught B; Liao WS; Rosen JM
Mol Endocrinol; 1995 Sep; 9(9):1223-32. PubMed ID: 7491114
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
16. C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage.
Welm AL; Timchenko NA; Darlington GJ
Mol Cell Biol; 1999 Mar; 19(3):1695-704. PubMed ID: 10022857
[TBL] [Abstract][Full Text] [Related]
17. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
19. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
